Discover our new products and the latest promotional offers for the Mimix™ reference standards. Bookmark this page and check back often, as it is updated regularly
Mimix™ Reference Standards New Products
 |
Seven mutations with clinical relevance in oncology testing, selected by industry experts, have been engineered into a Genome-in-a-Bottle Consortium cell line. The result is a highly characterized somatic cancer reference standard that you can trust to verify and monitor your oncology detection assays and workflow. This industry-first pan-cancer dual DNA/RNA reference material has been developed in collaboration with the Medical Device Innovation Consortium (MDIC). A negative control is also available (HD876-IVD) For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability. Learn more |
 |
Detect lung cancer mutations with greater confidence. These reference standards are quality, cancer-specific controls to support the precise identification of somatic variants. Together, they serve as a source for testing paired sample sets to evaluate the comprehensive performance of molecular biology assays.
|
 |
An industry-first pan-cancer dual DNA/RNA reference material developed in collaboration with the Medical Device Innovation Consortium (MDIC). Seven cancer mutations with clinical relevance, as selected by industry experts, have been engineered into a Genome-in-a-Bottle Consortium cell line, providing a highly characterized somatic cancer reference standard you can trust to verify and monitor your oncology detection assays and workflow.
|
 |
A cell line-derived pan-cancer reference standard, featuring 11 variants across 6 key cancer genes. These variants range from 0.8-24.5% allelic frequency (AF), to aid in the limit of detection (LOD) determination of your assay.
|
 |
This reference standard is a commutable control material consisting of a blend of human cancer cell lines that have been fixed in formalin and embedded in paraffin blocks, and feature 386 variants across 152 essential cancer genes.
|
 |
This reference standard is a commutable genomic DNA control material, consisting of extracted genomic DNA from a blend of human cancer cell lines and containing 386 variants across 152 key cancer genes.
|
 |
Mimix™ Myeloid Cancer Panel gDNA Reference Standard IVD
|
 |
The Mimix OncoPure Colorectal Cancer FFPE reference standard is a cancer-specific quality control for evaluating the performance of molecular biology assays. It offers a highly accurate representation of patient samples, and is derived from a single CRC tumor cell line without any modifications or engineering.Learn more |
 |
Developed based on customer feedback, the Mimix Quantitative Multiplex Moderate FFPE reference standard is a biologically-relevant quality control material for assessing the performance of molecular biology assays that detect somatic mutation. It has more degraded DNA than the standard Quantitative Multiplex FFPE product (HD200) to even more closely mimic patient samples in research set-ups.Learn more |
 |
This Mimix gDNA reference standard is a biologically-relevant quality control material which can be used to assess the performance and consistency of various molecular biology assays such as qPCR, ddPCR, Sanger sequencing and NGS.Learn more |
Promotions
Save now with our current promotions
